Literature DB >> 16787209

Gene-gene and gene-environment interplay represent specific susceptibility for different types of ischaemic stroke and leukoaraiosis.

Zoltán Szolnoki1, Béla Melegh.   

Abstract

Stroke is a very frequent entity. It is the third leading cause of death and the leading cause of adult disability in the developed world. At a population level, the common sporadic form of ischaemic stroke is underpinned by both environmental and genetic risk factors. Typically, in clinical practice, environmental risk factors such as hypertension, diabetes mellitus, smoking, alcohol consumption, and other factors, are usually considered to be more important than genetic factors. However, it is the interplay of both environmental and common genetic factors [such as the Leiden V, methylenetetrahydrofolate reductase C677T, apolipopotein E 4, endothelial nitric oxide synthase G894T, angiotensin-converting enzyme I/D and angiotensin II type 1 receptor A1166C mutations and polymorphisms] that leads to the development of ischaemic stroke. Indeed, a complex network of interactions between genetic factors and clinical risk factors can be supposed. This review evaluates the possible roles of gene-gene and gene-environment interactions concerning the above genetic factors in the evolution of ischaemic stroke and leukoaraiosis. A knowledge of the specific genetic patterns which are associated with a significant risk of ischaemic stroke or leukoaraiosis may also draw attention to a large population at an increased risk of circulatory disorders. This may facilitate the choice of more effective and specific prevention on the basis of the genotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16787209     DOI: 10.2174/092986706777441931

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  11 in total

1.  Polymorphisms of the renin-angiotensin system are associated with blood pressure, atherosclerosis and cerebral white matter pathology.

Authors:  M J E van Rijn; M J Bos; A Isaacs; M Yazdanpanah; A Arias-Vásquez; B H Ch Stricker; O H Klungel; B A Oostra; P J Koudstaal; J C Witteman; A Hofman; M M B Breteler; C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-12       Impact factor: 10.154

2.  The SG13S114 polymorphism of the ALOX5AP gene is associated with ischemic stroke in Europeans: a meta-analysis of 8062 subjects.

Authors:  Zhongjun Chen; Jinyu Zheng; Wenguang Liu; Kun Yang; Kai Li; Baosheng Huang; Ronglan Zhu; Xiaocheng Lu; Lixin Li
Journal:  Neurol Sci       Date:  2017-01-18       Impact factor: 3.307

3.  Association of lipopolysaccharide-binding protein gene polymorphisms with cerebral infarction in a Chinese population.

Authors:  Q Zhan; M Yuan; X H Wang; X M Duan; Q D Yang; J Xia
Journal:  J Thromb Thrombolysis       Date:  2012-08       Impact factor: 2.300

4.  Family-based association study of matrix metalloproteinase-3 and -9 haplotypes with susceptibility to ischemic white matter injury.

Authors:  Myriam Fornage; Thomas H Mosley; Clifford R Jack; Mariza de Andrade; Sharon L R Kardia; Eric Boerwinkle; Stephen T Turner
Journal:  Hum Genet       Date:  2006-09-22       Impact factor: 4.132

5.  The combination of homozygous MTHFR 677T and angiotensin II type-1 receptor 1166C variants confers the risk of small-vessel-associated ischemic stroke.

Authors:  Zoltan Szolnoki; Anita Maasz; Lili Magyari; Katalin Horvatovich; Bernadett Farago; Ferenc Somogyvari; Andras Kondacs; Mihaly Szabo; Anita Bodor; Ferenc Hadarits; Bela Melegh
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

6.  C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of ischemic stroke in Polish subjects.

Authors:  I Goracy; L Cyryłowski; M Kaczmarczyk; A Fabian; D Koziarska; J Goracy; A Ciechanowicz
Journal:  J Appl Genet       Date:  2009       Impact factor: 3.240

7.  Three periods of one and a half decade of ischemic stroke susceptibility gene research: lessons we have learned.

Authors:  Anita Maasz; Bela Melegh
Journal:  Genome Med       Date:  2010-09-13       Impact factor: 11.117

Review 8.  Buying time: a rationale for examining the use of circadian rhythm and sleep interventions to delay progression of mild cognitive impairment to Alzheimer's disease.

Authors:  Glenn J Landry; Teresa Liu-Ambrose
Journal:  Front Aging Neurosci       Date:  2014-12-08       Impact factor: 5.750

9.  Complexity in the genetic architecture of leukoaraiosis in hypertensive sibships from the GENOA Study.

Authors:  Jennifer A Smith; Stephen T Turner; Yan V Sun; Myriam Fornage; Reagan J Kelly; Thomas H Mosley; Clifford R Jack; Iftikhar J Kullo; Sharon L R Kardia
Journal:  BMC Med Genomics       Date:  2009-04-07       Impact factor: 3.063

10.  Endothelial nitric oxide synthase Glu298Asp gene polymorphism is associated with hypertensive response to exercise in well-controlled hypertensive patients.

Authors:  Jung-Sun Kim; Jung Rae Cho; Sungha Park; Jaemin Shim; Jin-Bae Kim; Deok-Kyu Cho; Hyun-Joon Shin; Chan Mi Park; Young-Guk Ko; Jong-Won Ha; Donghoon Choi; Se-Joong Rim; Yangsoo Jang; Namsik Chung
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.